These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 19757443)

  • 1. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection.
    Uen YH; Lu CY; Tsai HL; Yu FJ; Huang MY; Cheng TL; Lin SR; Wang JY
    Ann Surg Oncol; 2008 Aug; 15(8):2120-8. PubMed ID: 18481151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection.
    Tsai HL; Cheng KI; Lu CY; Kuo CH; Ma CJ; Wu JY; Chai CY; Hsieh JS; Wang JY
    J Surg Oncol; 2008 Apr; 97(5):383-7. PubMed ID: 18163435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative borderline elevated CEA predicts for earlier relapse in patients with rectal cancer receiving adjuvant postoperative therapy.
    Dawson LA; Franssen E; Davey P
    Cancer J Sci Am; 1999; 5(6):374-9. PubMed ID: 10606480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
    Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
    Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
    Huh JW; Kim HR; Kim YJ
    Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
    Yamamoto S; Akasu T; Fujita S; Moriya Y
    Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of prognostic determinants for colorectal cancer patients with high preoperative serum CEA levels: prognostic value of postoperative serum CEA levels.
    Ma CJ; Hsieh JS; Wang WM; Su YC; Huang CJ; Huang TJ; Wang JY
    Kaohsiung J Med Sci; 2006 Dec; 22(12):604-9. PubMed ID: 17116621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection.
    Fujita S; Shimoda T; Yoshimura K; Yamamoto S; Akasu T; Moriya Y
    J Surg Oncol; 2003 Nov; 84(3):127-31. PubMed ID: 14598355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA.
    Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ
    Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can preoperative and postoperative CEA predict survival after colon cancer resection?
    Slentz K; Senagore A; Hibbert J; Mazier WP; Talbott TM
    Am Surg; 1994 Jul; 60(7):528-31; discussion 531-2. PubMed ID: 8010568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
    Law WL; Ho JW; Chan R; Au G; Chu KW
    Dis Colon Rectum; 2005 Feb; 48(2):218-26. PubMed ID: 15711860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Yeh YS; Chang YT; Yang IP; Lin CH; Kuo CH; Juo SH; Wang JY
    J Surg Oncol; 2013 Feb; 107(2):148-54. PubMed ID: 22926658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in survival of colorectal cancer patients after surgery.
    Mehrkhani F; Nasiri S; Donboli K; Meysamie A; Hedayat A
    Colorectal Dis; 2009 Feb; 11(2):157-61. PubMed ID: 18462239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.